reglab/statecodes huggingface dataset:
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 2 - Personnel › 12 AAC 52.245 - Retired status pharmacist license

Current through May 31, 2024
(a) Upon retiring
				  from practice, an individual holding an unencumbered pharmacist license in the
				  state that is not under investigation with the board may apply for the
				  conversion of an active or inactive pharmacist license to a retired status
				  pharmacist license.
(b) An
				  individual holding a retired status pharmacist license may use the title
				  "pharmacist-retired" but may not practice or indicate that the individual is
				  practicing or soliciting to practice as a pharmacist in the state.
(c) A retired status pharmacist license is
				  valid for the life of the holder, does not require renewal, and is exempt from
				  continuing education requirements.
(d) The executive administrator or board will
				  issue a retired status pharmacist license to an individual who meets the
				  requirements of (a) of this section if the applicant
(1) submits a completed retired status
				  application on a form provided by the department; and
(2) pays the retired status pharmacist
				  license one-time fee set out under
				  12 AAC 02.310.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 3 - License Renewal and Continuing Education Requirements › 12 AAC 52.300 - License and registration renewal

Current through May 31, 2024
(a) Pharmacy,
				  remote pharmacy, wholesale drug distributor, outsourcing facility, third-party
				  logistics provider, manufacturer, pharmacist, pharmacy technician, and drug
				  room licenses must be renewed biennially on or before a date set by the
				  department.
(b) An applicant for
				  renewal of a pharmacy, wholesale drug distributor, outsourcing facility,
				  third-party logistics provider, manufacturer, or drug room license must submit
				  on or before the license expiration date
(1)
				  a completed renewal application on a form provided by the department;
(2) the license renewal fees required in
				  12 AAC 02.310; and
(3) an attestation that a self-inspection of
				  the premises using the form provided by the department was completed within the
				  last two years or since the last time the license was initially issued; the
				  applicant must retain the self-inspection and make it available to the board
				  upon request for the duration of the licensing period in which it was I
				  completed.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 3 - License Renewal and Continuing Education Requirements › 12 AAC 52.310 - Reinstatement of a lapsed pharmacist or pharmacy technician license

Current through May 31, 2024
(a) If a
				  pharmacist's or pharmacy technician's license has lapsed for any reason, that
				  pharmacist or pharmacy technician may not practice pharmacy until the board
				  reinstates the license.
(b) The
				  board will reinstate a pharmacist or pharmacy technician license that has been
				  lapsed less than two years if the applicant submits
(1) a completed renewal
				  application;
(2) any applicable
				  license renewal fees required under
				  12 AAC 02.310; and
(3) documentation that the applicant has
				  completed all continuing education requirements under
				  12 AAC 52.320 -
				  12 AAC 52.350 within the immediate
				  two years before applying for reinstatement.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 3 - License Renewal and Continuing Education Requirements › 12 AAC 52.320 - Continuing education requirements for pharmacists

Current through May 31, 2024
(a) Except as
				  provided in (c) of this section, an applicant for renewal of a pharmacist
				  license shall certify having completed 30 contact hours of continuing education
				  accepted by the board under
				  12 AAC 52.340(a)
				  during the concluding license period.
(b) This section does not prevent the board
				  from imposing additional continuing education requirements under its
				  disciplinary powers.
(c) An
				  individual who is applying for renewal of a pharmacist license for the first
				  time shall certify having completed one half of the continuing education
				  requirements in (a) of this section for each complete 12 month period that the
				  applicant was licensed during the concluding license period.
(d) An applicant for reinstatement of a
				  pharmacist license that has expired shall certify that the applicant completed
				  the continuing education requirements in (a) of this section before applying
				  for reinstatement.
(e) A pharmacist
				  administering a vaccine or related emergency medication under 12 AAC 52.992
				  shall certify having completed one hour of Accreditation Council for Pharmacy
				  Education (ACPE) approved continuing education specific to immunizations or
				  vaccines as part of the 30 contact hours of continuing education required under
				  (a) of this section.
Authority:
AS
						08.80.005
AS
						08.80.030
AS
						08.80.147
AS
						08.80.165
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 3 - License Renewal and Continuing Education Requirements › 12 AAC 52.325 - Continuing education requirements for pharmacy technicians

Current through May 31, 2024
(a) Except as
				  provided in (c) of this section, an applicant for renewal of a pharmacy
				  technician license shall certify that, during the concluding licensing period,
				  the applicant
(1) completed 10 contact hours
				  of continuing education accepted by the board under
				  12 AAC 52.340; or
(2) obtained initial certification as a
				  pharmacy technician by the Pharmacy Technician Certification Board
				  (PTCB).
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 3 - License Renewal and Continuing Education Requirements › 12 AAC 52.330 - Alternative continuing education schedule

Current through May 31, 2024
An individual licensed under AS 08.80 may apply to the
					 board for an alternative schedule of continuing education if the individual's
					 failure to meet the continuing education requirements in
					 12 AAC 52.320 is due to illness or
					 other extenuating circumstances.
Authority:
AS
						08.80.005
AS 08.80.030
AS
						08.80.165
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 3 - License Renewal and Continuing Education Requirements › 12 AAC 52.340 - Approved programs

Current through May 31, 2024
(a) The following programs will be accepted
				  by the board as continuing education for pharmacists and pharmacy technicians
				  under 12 AAC 52.320 and
				  12 AAC 52.325:
(1) any program presented by a provider
				  accredited by the ACPE that results in a continuing education certificate
				  showing the date of the course and the ACPE Universal Activity Number
				  associated with the program;
(2)
				  cardiopulmonary resuscitation (CPR) courses presented by the American Red Cross
				  or the American Heart Association that lead to CPR certification; the board
				  will accept no more than one contact hour of continuing education credit in a
				  24 month period for completion of a CPR course.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 3 - License Renewal and Continuing Education Requirements › 12 AAC 52.350 - Audit of records by the board

Current through May 31, 2024
(a) The board will
				  randomly audit renewal applications for verification of reported continuing
				  education contact hours. To conduct an audit under this section, the board will
				  access and evaluate continuing pharmacy education data reported to the
				  ACPE-NABP CPE Monitor Service during the time period audited.
(b) Upon written request, a pharmacist or
				  pharmacy technician shall provide the board with a copy of each certificate of
				  completion for the continuing education units not reported to the ACPE-NABP CPE
				  Monitor Service during the time period audited by the board.
(c) If the board disallows any continuing
				  education contact units reported on behalf of or by a pharmacist or pharmacy
				  technician, the pharmacist or pharmacy technician shall
(1) complete the number of disallowed contact
				  hours in an approved program and report the completion to the board no later
				  than 90 days after the date the board sends notification of the disallowed
				  contact hours; and
(2) provide the
				  board with copies of certificates of completion for all continuing education
				  units
(A) not reported to the ACPE-NABP CPE
				  Monitor Service; and
(B) completed
				  for the next two licensing periods.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.400 - General guidelines for pharmacies

Current through May 31, 2024
A person that is required to be licensed by AS 08.80 and
					 who has a license under AS 08.80 and this chapter shall adhere to the
					 guidelines on facilities, reference material, equipment, supplies, and other
					 guidelines established by the board in the pamphlet titled,
"Facility
					 Standards for Pharmacies,"
d ated November 2016, and incorporated by
					 reference in this section.
Click here to view
					 image
The pamphlet incorporated by reference in
						12 AAC 52.400, "Facility Standards
						for Pharmacies" may be obtained from the Department of Commerce, Community, and
						Economic Development, Division of Corporations, Business and Professional
						Licensing, Board of Pharmacy, State Office Building, 9th Floor, 333 Willoughby
						Avenue, Juneau, Alaska 99801; phone (907) 465-2589.
Authority:
AS
						08.80.005
AS
						08.80.030
AS
						08.80.157
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.410 - Care of drug stocks and devices

Current through May 31, 2024
(a) A drug or
				  device that has exceeded its expiration date shall be removed from stock and
				  quarantined until properly disposed of in accordance with
				  12 AAC 52.560.
(b) A pharmacist may not dispense a drug or
				  device beyond the expiration date on the drug or device.
(c) All drugs and devices on shelves or
				  display for sale shall be protected against contamination, deterioration, and
				  adulteration.
Authority:
AS
						08.80.005
AS 08.80.030
AS
						08.80.157
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.420 - Security

Current through May 31, 2024
(a) Each pharmacist, while on duty, is
				  responsible for the security of the pharmacy, including effective control
				  against theft or diversion of drugs.
(b) The pharmacist-in-charge is responsible
				  for compliance with all prescription department security
				  requirements.
(c) Excluding
				  prescription drugs or devices held within an automated distribution kiosk, all
				  drugs, devices, and other items or products that are restricted to sale by or
				  under the direct supervision of a pharmacist shall be kept in the prescription
				  department.
(d) Excluding
				  prescription drugs or devices held within an automated distribution kiosk, the
				  prescription department shall be secured to prevent unauthorized access when a
				  pharmacist is not available to provide direct supervision.
(e) A pharmacy with service hours differing
				  from the remainder of the business establishment must have a telephone number
				  that is separate from the remainder of the business establishment.
(f) Excluding prescription drugs or devices
				  held within an automated distribution kiosk, prescriptions shall be stored in
				  the prescription department and may be removed only under the direct
				  supervision of a pharmacist and for immediate delivery to the patient, the
				  patient's agent, or the person delivering the prescription to the patient or
				  the patient's agent.
(g) A
				  pharmacist shall provide adequate security for prescription records to prevent
				  unauthorized access to confidential health information.
(h) In this section, "prescription
				  department" means the area of the pharmacy where prescription drugs are
				  stored.
Authority:
AS
						08.80.005
AS 08.80.030
AS 08.80.157
AS
						08.80.315
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.423 - Remote pharmacy license

Current through May 31, 2024
(a) A central
				  pharmacy that wishes to provide pharmacy services through a remote pharmacy in
				  the state using a telepharmacy system as provided in
				  12 AAC 52.425 must apply to the
				  board for a remote pharmacy license. The central pharmacy applying under this
				  section for a remote pharmacy license must
(1) submit to the department a complete
				  notarized application on a form provided by the department;
(2) submit to the department the applicable
				  fees established under
				  12 AAC 02.310;
(3) comply with the requirements of
				  12 AAC 52.020; and
(4) provide the name and active or pending
				  license number of the central pharmacy.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.425 - Telepharmacy system for a remote pharmacy

Current through May 31, 2024
(a) Only a
				  pharmacist employed by a central pharmacy located in this state may provide
				  pharmacy services to a remote pharmacy through a telepharmacy system. A
				  telepharmacy system must be conducted under the direct supervision of a
				  pharmacist located in this state. The pharmacist-in-charge of a remote pharmacy
				  may supervise one or more remote pharmacies.
(b) Before a pharmacist employed by a central
				  pharmacy may provide pharmacy services to a remote pharmacy, the telepharmacy
				  system between the central pharmacy and remote pharmacy must be tested by the
				  supervising pharmacist of the central pharmacy and found to operate properly.
				  The supervising pharmacist of the central pharmacy shall make the results of
				  the test available to the board upon request. The computer link and video link
				  with sound of the telepharmacy system must include at least one of the
				  following:
(1) still image capture;
(2) real time link;
(3) store and forward.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.430 - Guidelines relating to sterile pharmaceuticals

Current through May 31, 2024
A pharmacy or pharmacist that prepares or dispenses sterile
					 pharmaceuticals shall adhere to the guidelines established by the board in the
					 pamphlet titled,
"Sterile Pharmaceuticals,"
dated February
					 2008, and incorporated by reference in this section.
The pamphlet incorporated by reference in
						12 AAC 52.430, "Sterile
						Pharmaceuticals" may be obtained from the Department of Commerce, Community,
						and Economic Development, Division of Corporations, Business and Professional
						Licensing, Board of Pharmacy, State Office Building, 9th Floor, 333 Willoughby
						Avenue, Juneau, Alaska 99801; phone (907) 465-2589.
As of Register 171 (October 2004), the regulations
						attorney made technical revisions under
						AS
						44.62.125(b)(6) to reflect
						the name change of the Department of Community and Economic Development to the
						Department of Commerce, Community, and Economic Development made by ch. 47, SLA
						2004 and the corresponding title change of the commissioner of community and
						economic development.
Authority:
AS
						08.80.030
AS
						08.80.157
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.440 - Guidelines relating to compounding practices

Current through May 31, 2024
A pharmacy or pharmacist that compounds drugs shall adhere
					 to the guidelines established by the board in the pamphlet titled,
"Compounding Practices,"
dated February 2008, and incorporated
					 by reference in this section.
The pamphlet incorporated by reference in
						12 AAC 52.440, "Compounding
						Practices" may be obtained from the Department of Commerce, Community, and
						Economic Development, Division of Corporations, Business and Professional
						Licensing, Board of Pharmacy, State Office Building, 9th Floor, 333 Willoughby
						Avenue, Juneau, Alaska 99801; phone (907) 465-2589.
As of Register 171 (October 2004), the regulations
						attorney made technical revisions under
						AS
						44.62.125(b)(6) to reflect
						the name change of the Department of Community and Economic Development to the
						Department of Commerce, Community, and Economic Development made by ch. 47, SLA
						2004 and the corresponding title change of the commissioner of community and
						economic development.
Authority:
AS
						08.80.030
AS
						08.80.157
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.443 - Approval for shared pharmacy services by pharmacy

Current through May 31, 2024
(a) A requesting
				  pharmacy in this state that seeks to participate in shared pharmacy services
				  must apply to the board for approval on a form provided by the
				  department.
(b) The board will
				  approve an application by a requesting pharmacy to participate in shared
				  pharmacy services if the pharmacy establishes
(1) that the pharmacy has a current in-state
				  pharmacy license issued under
				  AS
				  08.80.157 and this chapter;
(2) that the pharmacy is able to comply with
				  the requirements of
				  12 AAC 52.445;
(3) that the pharmacy either
(A) is owned by the same owner as the filling
				  pharmacy with which pharmacy services are to be shared; or
(B) has a written contract or agreement with
				  the filling pharmacy or filling pharmacist that outlines the pharmacy services
				  to be provided and the obligation of each pharmacy or pharmacist to comply with
				  federal and state pharmacy statutes and regulations; and
(4) that the participants in shared pharmacy
				  services share a common electronic file or other appropriate technology that
				  allows access to the information needed to provide shared pharmacy services in
				  compliance with the requirements of AS 08.80 and this chapter.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.444 - Approval for shared pharmacy services by pharmacists

Current through May 31, 2024
(a) A requesting
				  pharmacist in this state that seeks to participate in shared pharmacy services
				  must apply to the board for approval on a form provided by the
				  department.
(b) The board will
				  approve an application by a requesting pharmacist to participate in shared
				  pharmacy services if the pharmacist establishes
(1) that the pharmacist
(A) has a current in-state pharmacy license
				  issued under AS 08.80 and this chapter;
(B) has a written contract or agreement with
				  the filling pharmacy or filling pharmacist that outlines the pharmacy services
				  to be provided and the obligations of each pharmacy or pharmacist to comply
				  with federal and state pharmacy statutes and regulations; and
(C) is able to comply with the requirements
				  of 12 AAC 52.445; and
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.445 - Shared pharmacy services

Current through May 31, 2024
(a) A pharmacy
				  participating in shared pharmacy services, or a pharmacist acting independently
				  of a pharmacy and participating in shared pharmacy services, shall use an
				  identifier on the prescription container that identifies prescriptions to be
				  filled at a filling pharmacy or by the filling pharmacist. The requesting
				  pharmacy or requesting pharmacist shall notify the patient or the patient's
				  agent that the patient's prescription order may be processed or filled by
				  another pharmacy or pharmacist, and shall identify the filling pharmacy or
				  filling pharmacist. If the requesting pharmacy is part of a network of
				  pharmacies under common ownership, and the prescription order may be processed
				  or filled at any of the pharmacies in the network, the requesting pharmacy
				  shall notify the patient of this. Notice under this subsection may be provided
				  through an initial written notice to the patient or the patient's agent, or
				  through the use of a sign prominently displayed in the requesting pharmacy or
				  in the public portion of the office of the requesting pharmacist.
(b) Except as provided in (c) of this
				  section, if a filling pharmacy or filling pharmacist delivers a prescription
				  medication directly to the patient or the patient's agent, the filling pharmacy
				  or filling pharmacist shall provide, on the prescription container or on a
				  separate sheet delivered with the prescription container,
(1) the local telephone number and, if
				  applicable, the toll-free telephone number of the filling pharmacy or filling
				  pharmacist; and
(2) a statement
				  that conveys to the patient or patient's agent the following information:
				  "Written information about this prescription has been provided for you; please
				  read this information before you take the medication. If you have questions
				  concerning this prescription, a pharmacist is available during normal business
				  hours to answer these questions at [insert the filling pharmacist or filling
				  pharmacy's telephone numbers]."
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 4 - Guidelines for Pharmacies and Pharmacists › 12 AAC 52.446 - Shared pharmacy services during emergency

Current through May 31, 2024
(a) Notwithstanding
				  12 AAC 52.445, during a disaster
				  emergency declared by the governor, a pharmacy participating in shared pharmacy
				  services, or a pharmacist acting independently of a pharmacy and participating
				  in shared pharmacy services, shall do so in accordance with this
				  section.
(b) During a disaster
				  emergency declared by the governor, a pharmacist, pharmacist intern, or
				  pharmacy licensed or registered under AS 08.80 may participate in shared
				  pharmacy services without applying for approval under
				  12 AAC 52.443 and
				  12 AAC 52.444.
(c) Except as provided in (d) of this
				  section, if a filling pharmacy or filling pharmacist or pharmacist intern
				  delivers a prescription medication directly to the patient or the patient's
				  agent, the filling pharmacy or filling pharmacist or pharmacist intern shall
				  provide, on the prescription container or on a separate sheet delivered with
				  the prescription container, the local telephone number and, if applicable, the
				  toll-free telephone number of the filling pharmacy or filling
				  pharmacist.
(d) The requirement of
				  (c) of this section does not apply to prescription medication delivered to
				  patients in facilities where a licensed health care professional is responsible
				  for administering the prescription medication to the patient.
(e) A pharmacy participating in shared
				  pharmacy services, or a pharmacist acting independently of a pharmacy and
				  participating in shared pharmacy services, shall maintain manual or electronic
				  records identifying, individually for each order processed, filled or
				  dispensed,
(1) the name, initials, or
				  identification code of each pharmacist or pharmacist intern responsible for the
				  final verification of dispensing; and
(2) the patient, date, drug, strength, directions, and quantity
				  dispensed.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.450 - Prescription drug order records

Current through May 31, 2024
(a) A pharmacy
				  shall maintain prescription drug orders for a period of two years from the date
				  of filling or the date of the last dispensed refill. The prescription drug
				  orders shall be maintained in a manner that ensures they will remain legible
				  for the required two-year period.
(b) To comply with (a) of this section, a
				  pharmacy shall maintain the prescription drug orders by
(1) keeping the original hard copy
				  prescription drug order presented by a patient;
(2) keeping a plain paper version of the
				  prescription dmg order received by facsimile or digital electronic transmittal;
(3) keeping a prescription drug
				  order put into writing either manually or electronically by the pharmacist; or
(4) electronicall storing and
				  maintaining the precription drug order in a readily retrievable format.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.460 - Prescription drug order information

Current through May 31, 2024
(a) Before a
				  pharmacist may fill a prescription drug order, the pharmacist shall obtain the
				  following information:
(1) name of the
				  patient or, if the prescription drug order is for an animal, species of the
				  animal and name of the owner;
(2)
				  address of the patient unless the prescription drug order is for a
				  noncontrolled substance and the address is readily retrievable on another
				  appropriate, uniformly maintained pharmacy record, such as a patient medication
				  record;
(3) name and, if the
				  prescription drug order is for a controlled substance, the address and DEA
				  registration number of the prescribing practitioner;
(4) name and strength of the drug
				  prescribed;
(5) quantity
				  prescribed;
(6) directions for
				  use;
(7) date of issue;
(8) refills authorized, if any;
(9) if a written or hard copy prescription
				  drug order, the prescribing practitioner's handwritteg, digital, electronic, or
				  stamped signature;
(10) if a
				  prescription drug order is received by the pharmacy as a facsimile, the
				  prescribing practitioner's handwritten, digital, electronic, or stamped
				  signature or authorized agent's signature; and
(11) if the rescrition drug order is signed
				  by an authorized agent, the name of the prescribing practitioner.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.465 - Controlled substance prescription drug orders

Current through May 31, 2024
A prescription drug order for a schedule II controlled
					 substance may be partially filled if prescribed for
(1) a terminally ill patient or a patient
				  residing in a long term care facility, in accordance with  21C.F.R 1306.13;
				  or
(2) a patient who is not
				  terminally ill or residing in a long term care facility if
(A) the partial fill is requested by the
				  patient or the practitioner that wrote the prescription;
(B) the total quantity dispensed in all
				  partial filling does not exceed the total quantity prescribed;
(C) each partial fill is electronically
				  documented in the patient record;
(D) the remaining portions are filled not
				  later than 30 days after the date on which the prescription is written;
				  and
(E) each partail fill only
				  occurs at the pharmacy where the original prescription order is on
				  file.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.470 - Refills

Current through May 31, 2024
(a) A pharmacist may dispense a refill of a
				  prescription drug order only in accordance with the prescribing practitioner's
				  authorization as indicated on the prescription drug order. If there are no
				  refill instructions on the prescription drug order, or if all refills
				  authorized on the original prescription drug order have been dispensed, a
				  pharmacist shall obtain authorization from the prescribing practitioner before
				  dispensing a refill.
(b) A
				  pharmacist may not dispense a refill of a prescription drug order for a
				  noncontrolled substance after one year from the date of issue of the original
				  prescription drug order.
(c) Each
				  time a prescription drug order refill is dispensed, the pharmacist shall record
				  the refill electronically or on the back of the prescription drug order by
				  listing the date of dispensing, the written initials or identification code of
				  the dispensing pharmacist, and the amount dispensed if different from the
				  quantity on the original prescription drug order.
(d) A pharmacist or pharmacist intern may
				  dispense any quantity of a prescription drug order so long as the total
				  quantity of dosage units dispensed does not exceed the total quantity of dosage
				  units authorized by the prescriber, including refills.
(e) To indicate that an increased supply may
				  not be dispensed under this this section, a prescriber may indicate "no change
				  to quantity", or words of similar meaning, on the prescription drug
				  order.
(f) Nothing in this section
				  requires a health care service plan, health JI insurer, workers' compensation
				  insurance plan, pharmacy benefits manager, or any other person or entity,
				  including a state program or state employer, to provide coverage for a drug in
				  a manner inconsistent with a beneficiary's plan benefit.
Authority:
AS
						08.80.005
AS
						08.80.030
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.480 - Labeling

Current through May 31, 2024
One or more labels containing the following information
					 shall be affixed to every container in which a prescription drug order is
					 dispensed:
(1) name, address, and
				  phone number of the dispensing pharmacy;
(2) unique identification number of the
				  prescription drug order;
(3) date
				  the prescription drug order is dispensed;
(4) initials of the dispensing
				  pharmacist;
(5) name of the
				  prescribing practitioner;
(6) name
				  of the patient or, if the drug was prescribed for an animal, the species of
				  animal and the name of the owner;
(7) directions for use;
(8) quantity dispensed;
(9) appropriate ancillary instructions or
				  cautions;
(10) if the prescription
				  drug order is for a schedule II-V controlled substance, the statement,
				  "Caution: Federal law prohibits the transfer of this drug to any person other
				  than the patient for whom it was prescribed";
(11) the name and strength of the actual drug
				  product dispensed, unless otherwise directed by the prescribing
				  practitioner;
(12) the accepted
				  generic drug name and strength of the drug dispense; if the drug product
				  dispensed has multiple ingredients, the pharmacist shall provide this
				  information in writing to the patient or the patient's agent.
Authority:
AS
						08.80.005
AS 08.80.030
AS 08.80.295
AS
						08.80.480
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.490 - Prescriptions by electronic transmission

Current through May 31, 2024
(a) Legend drug and
				  controlled substance prescriptions may be transmitted electronically under this
				  section, consistent with state and federal laws. A pharmacist may dispense a
				  prescription transmitted electronically under this section only if the
				  prescribing practitioner includes the following information on the prescription
				  before it is transmitted:
(1) name, address,
				  and telephone number of the prescribing practitioner;
(2) electronic signature or manual signature
				  of the prescribing practitioner;
(3) the information required in
				  12 AAC 52.460(a) (1) - (8); and
(4) any other information required by federal
				  law.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.500 - Transfer of a prescription drug order

Current through May 31, 2024
(a) For the purpose
				  of dispensing a prescription drug order, original prescription drug order
				  information may be transferred between pharmacies if the requirements of
				  12 AAC 52.460 and this section are
				  met.
(b) Original prescription drug
				  order information for controlled substances listed in schedules II, III, IV, or
				  V may be transferred only by the pharmacy that originally received the
				  prescription drug order from the prescribing practitioner. The transfer must be
				  communicated directly between two licensed pharmacists.
(c) Original prescription drug order
				  information for noncontrolled substances may be transferred verbally,
				  electronically, or by means of facsimile between pharmacies without limitation
				  up to the number of originally authorized refills.
(d) A pharmacy transferring a prescription
				  drug order or receiving a transferred prescription drug order must meet the
				  following requirements:
(1) if transferred
				  verbally, the transfer shall be communicated directly between two licensed
				  pharmacists;
(2) both the original
				  and the transferred prescription drug order must meet the requirements of
				  12 AAC 52.450(a);
(3) the pharmacist transferring the
				  prescription drug order information shall record the following information:
(i) the name, address, and if a controlled
				  substance, the DEA registration number of the pharmacy receiving the
				  prescription drug order information;
(ii) the name of the pharmacist receiving the
				  prescription drug order information;
(iii) the name of the pharmacist transferring
				  the prescription drug order information; and
(iv) the date of the transfer;
(4) the pharmacist receiving the
				  transferred prescription drug order information shall record the following
				  information:
(i) the original date of issue
				  and date of dispensing, if different from the date of issue;
(ii) the original prescription drug order
				  number and the number of refills authorized on the original prescription drug
				  order;
(iii) the number of valid
				  refills remaining and the date of the last refill;
(iv) the name, address, and if a controlled
				  substance, the DEA registration number of the pharmacy transferring the
				  prescription drug order information; and
(v) the name of the pharmacist transferring
				  the prescription drug order information; and
(5) when a prescription drug order is
				  transferred, the transferring pharmacy may not issue any further
				  refills.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.510 - Substitution

Current through May 31, 2024
(a) A pharmacist may dispense an equivalent
				  drug product or interchangeable biological product instead of the prescribed
				  drug if
(1) the prescribing practitioner does
				  not indicate on the prescription drug order that a specific brand must be
				  dispensed, using language such as "brand medically necessary", "dispense as
				  written", "do not substitute", or other similar wording;
(2) the patient is notified and consents to
				  the substitution;
(3) repealed
				  10/31/2019; and
(4) for the drug
				  product actually dispensed, the pharmacy record contains one of the following:
(A) the drug product's manufacturer or
				  distributor;
(B) national drug code
				  number;
(C) short name code;
				  or
(D) trade name.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.520 - Customized patient medication package (patient med-pak)

Current through May 31, 2024
(a) Instead of
				  dispensing one or more prescribed drug products in separate containers, a
				  pharmacist may, with the written consent of the patient, patient's caregiver,
				  or prescribing practitioner, provide a customized patient medication package or
				  patient med-pak.
(b) A patient
				  med-pak is a series of containers prepared by a pharmacist for a specific
				  patient containing one or more prescribed solid oral dosage forms and designed
				  or labeled to indicate the day and time, or period of time, when the contents
				  within each container are to be taken.
(c) The pharmacist shall prepare a label for
				  a patient med-pak that includes
(1) the name
				  of the patient;
(2) the unique
				  identification number for the patient med-pak itself and a separate unique
				  identification number for each of the prescription drug orders for the drug
				  products in the patient med-pak;
(3) the name, strength, physical description
				  or identification, and total quantity of each drug product in the patient
				  med-pak;
(4) the directions for use
				  and cautionary statements, if any, contained in the prescription drug order for
				  each drug product in the patient med-pak;
(5) any other information, statements, or
				  warnings required or appropriate for any of the drug products in the patient
				  med-pak;
(6) the name of the
				  prescribing practitioner of each drug product in the patient med-pak;
(7) the date of preparation of the patient
				  med-pak and the expiration date assigned to the patient med-pak; the expiration
				  date may not be more than 60 days from the date of preparation of the patient
				  med-pak;
(8) the name, address, and
				  telephone number of the pharmacy; and
(9) the initials of the dispensing
				  pharmacist.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.530 - Return or exchange of drugs

Current through May 31, 2024
(a) A pharmacy or
				  pharmacist may accept a drug for return or exchange after the drug has been
				  taken from the premises where the drug was sold, distributed, or dispensed if
(1) the prescription was dispensed in a
				  manner inconsistent with the original prescription drug order; or the
				  medication was recalled by the manufacturer or the United States Food and Drug
				  Administration and
(2) the drug is
				  segregated from the normal pharmacy inventory and may not be
				  dispensed.
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.540 - Notification of theft or significant loss

Current through May 31, 2024
If a pharmacy is required under
					 21 U.S.C.
					 801 -
					 904 (Controlled Substances Act) to
					 complete DEA Form 106, "Report of Theft or Loss of Controlled Substances," the
					 pharmacist-in-charge shall also send a copy of the completed form to the
					 board.
Authority:
AS
						08.80.005
AS 08.80.030
AS
						08.80.157
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.550 - Advertising

Current through May 31, 2024
A pharmacy may advertise prescription drug prices if the
					 advertisement contains all of the following information:
(1) proprietary, trade, or generic name of
				  the drug product;
(2) name of the
				  manufacturer or distributor of the drug product;
(3) dosage form and strength of the drug
				  product;
(4) price charged for a
				  specific quantity of the drug product; and
(5) the hours that pharmaceutical services
				  are available from the advertiser.
Authority:
AS
						08.80.005
AS
						08.80.030
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.560 - Destruction and disposal of drugs

Current through May 31, 2024
(a) A licensed
				  pharmacist may destroy noncontrolled prescription drugs if the drugs are
				  destroyed in a manner that makes the drugs unfit for human
				  consumption.
(b) A drug that is a
				  controlled substance shall be disposed of in accordance with federal statutes
				  and regulations.
Authority:
AS
						08.80.005
AS
						08.80.030
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.570 - Drug regimen review

Current through May 31, 2024
(a) A pharmacist shall perform a drug regimen
				  review, as defined in
				  AS
				  08.80.480, for each prescription drug
				  order.
(b) If a pharmacist
				  identifies any of the items listed in
				  AS
				  08.80.480 during the drug regimen review, the
				  pharmacist shall avoid or resolve the problem by consulting with the
				  prescribing practitioner, if necessary.
Authority:
AS
						08.80.005
AS 08.80.030
AS
						08.80.480
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.580 - Data processing systems

Current through May 31, 2024
A pharmacy may use an automated data processing system to
					 maintain the records required in AS 08.80 and this chapter if the system
(1) is capable of on-line retrieval of all
				  information required in
				  12 AAC 52.460,
				  12 AAC 52.470, and
				  21 C.F.R.
				  1306.22, as amended as of February 6,
				  1997;
(2) is capable of producing
				  an audit trail printout for all dispensing of any specified strength and dosage
				  form of a drug; and
(3) has
				  adequate safeguards to prevent loss of data and reasonable security to prevent
				  unauthorized access to, modification of, or manipulation of patient
				  records.
Authority:
AS
						08.80.005
AS
						08.80.030
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.585 - Patient counseling

Current through May 31, 2024
(a) Following the review of a patient's
				  records, if considered necessary by the pharmacist, a pharmacist or pharmacist
				  intern shall personally offer counseling to each patient or the patient's
				  agent.
(b) If a pharmacist or
				  pharmacist intern provides counseling, the pharmacist or pharmacist intern may
				  provide the counseling by any verbal, written, or electronic means.
(c) This section does not apply to a
				  pharmacist who dispenses drugs for inpatient use in a hospital or other
				  institution if the drug is to be administered by a nurse or other appropriate
				  health care provider.
(d) Before
				  dispensing an opioid prescription for the first time to a patient or patient's
				  agent, or upon a dose increase, a pharmacist or pharmacist intern shall advise
				  the patient about the potential dangers of opioid dependency, overdose, and
				  interactions.
Authority:
AS
						08.80.005
AS
						08.80.030
AS
						08.80.480
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.590 - Prepackaging of drugs

Current through May 31, 2024
For the purpose of supplying drugs to a prescribing
					 practitioner, drugs shall be prepackaged in child-resistant containers under
					 the direct supervision of a pharmacist and bear a label that contains
(1) the name, address, and telephone number
				  of the pharmacy;
(2) the name,
				  strength, and quantity of the drug;
(3) the lot number and expiration date of the
				  drug, if not already contained on the unit-of-use or drug packaging;
(4) cautionary information required for
				  patient safety and information; and
(5) the initials of the pharmacist.
Authority:
AS
						08.80.005
AS 08.80.030
AS
						08.80.480
Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 5 - Pharmacy Practice Standards › 12 AAC 52.595 - Automated distribution kiosks

Current through May 31, 2024
(a) A licensed
				  pharmacy in this state may install and use an automated distribution kiosk that
				  is accessible to the patient or the patient's agent while the pharmacy is open
				  or closed for the purpose of purchasing the patient's completed prescription
				  drug orders if
(1) the kiosk is securely
				  installed on the same premises as the pharmacy and is properly secured to
				  prevent removal without the use of heavy or specialized equipment;
(2) before loading the completed
				  prescription drug order into the kiosk, the pharmacist counsels the patient in
				  accordance with
				  12 AAC 52.585; and
(3) no drugs defined by state or federal law
				  as controlled substances are placed in the kiosk, and the kiosk has a
				  conspicuously posted sign that states "This machine does not contain controlled
				  substances."; the sign must use a minimum of size 72 font and red
				  color.